This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Parker Elects Stryker CEO Kevin Lobo To Board Of Directors

CLEVELAND, July 2, 2013 /PRNewswire/ -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced the election of Kevin A. Lobo to its Board of Directors, effective August 1, 2013, for a term expiring in October 2013, at which time the entire Board will stand for election to a one year term at the Annual Meeting of Shareholders.

(Logo: http://photos.prnewswire.com/prnh/19990816/PHLOGO)

Mr. Lobo is currently President and Chief Executive Officer of Stryker Corporation, a leading medical technologies company that offers a diverse array of reconstructive, medical and surgical, and neurotechnology and spine products headquartered in Kalamazoo, Michigan. Mr. Lobo joined Stryker in April 2011, and served as Group President, Orthopaedics, where he had responsibility for the Reconstructive, Trauma & Extremities, Joint Preservation, Orthobiologics and Performance Solutions businesses.  He became President and Chief Executive Officer in October 2012 and is also a member of the Stryker Board of Directors.

"We are pleased to welcome Kevin Lobo to our Board and look forward to his insights and counsel," said Chairman, CEO and President Don Washkewicz. "Kevin has extensive experience leading large and diversified multi-national corporations in the medical technology industry, and his expertise will add significant value, particularly as Parker expands its presence in life sciences and related markets."

Prior to joining Stryker, Mr. Lobo held several senior leadership roles at Johnson & Johnson, including Worldwide President of Ethicon Endo-Surgery. Prior to that, he served as President of J&J Medical Products Canada and as Vice President of Finance for McNeil Consumer and Specialty Pharmaceuticals and Ortho Women's Health & Urology. His experience also includes positions with Rhone-Poulenc in North America and Europe, as well as Kraft and KPMG in Canada.

With annual sales of $13 billion in fiscal year 2012, Parker Hannifin is the world's leading diversified manufacturer of motion and control technologies and systems, providing precision-engineered solutions for a wide variety of mobile, industrial and aerospace markets. The company employs approximately 60,000 people in 48 countries around the world. Parker has increased its annual dividends paid to shareholders for 57 consecutive fiscal years, among the top five longest-running dividend-increase records in the S&P 500 index. For more information, visit the company's web site at www.parker.com, or its investor information web site at www.phstock.com.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs